Arroyo Vicente
Liver Unit, Institute of Digestive and Metabolic Diseases, Hospital Clinic, University of Barcelona, Barcelona, Spain.
Contrib Nephrol. 2007;156:17-23. doi: 10.1159/000102011.
Hepatorenal syndrome is a frequent complication in patients with cirrhosis, ascites and advanced liver failure. Its annual incidence in patients with ascites has been estimated at 8%. Hepatorenal syndrome is a functional renal failure due to low renal perfusion. Renal histology is normal or shows lesions that do not justify the decrease in glomerular filtration rate. The traditional concept is that hepatorenal syndrome is due to deterioration in circulatory function secondary to an intense vasodilation in the splanchnic circulation (peripheral arterial vasodilation hypothesis). Over the last decade, however, several features have suggested a much more complex pathogenesis. In this article new concepts on the pathogenesis of hepatorenal syndrome are reported, the current options for prophylaxis are shown, and the most applicable treatments are described.
肝肾综合征是肝硬化、腹水及晚期肝衰竭患者常见的并发症。据估计,腹水患者中其年发病率为8%。肝肾综合征是一种因肾灌注不足导致的功能性肾衰竭。肾脏组织学检查正常或显示的病变并不能解释肾小球滤过率的降低。传统观念认为,肝肾综合征是由于内脏循环强烈血管舒张继发循环功能恶化(外周动脉血管舒张假说)。然而,在过去十年中,一些特征提示其发病机制更为复杂。本文报告了肝肾综合征发病机制的新概念,展示了当前的预防措施,并描述了最适用的治疗方法。